161 related articles for article (PubMed ID: 20517105)
41. Severe granulomatous inflammatory response induced by injection of polyacrylamide gel into the facial tissue.
de Bree R; Middelweerd MJ; van der Waal I
Arch Facial Plast Surg; 2004; 6(3):204-6. PubMed ID: 15148133
[TBL] [Abstract][Full Text] [Related]
42. Long-term effects of polyacrylamide hydrogel on human breast tissue.
Christensen LH; Breiting VB; Aasted A; Jørgensen A; Kebuladze I
Plast Reconstr Surg; 2003 May; 111(6):1883-90. PubMed ID: 12711948
[TBL] [Abstract][Full Text] [Related]
43. A study on patients treated with polyacrylamide hydrogel injection for facial corrections.
Breiting V; Aasted A; Jørgensen A; Opitz P; Rosetzsky A
Aesthetic Plast Surg; 2004; 28(1):45-53. PubMed ID: 15116275
[TBL] [Abstract][Full Text] [Related]
44. Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated facial lipoatrophy: 18 months follow-up.
Rauso R; Freda N; Parlato V; Gherardini G; Amore R; Tartaro G
Dermatol Surg; 2011 Nov; 37(11):1584-9. PubMed ID: 21806709
[TBL] [Abstract][Full Text] [Related]
45. Early and late complications after a nonabsorbable hydrogel polymer injection: a series of 14 patients and novel management.
Goldan O; Georgiou I; Grabov-Nardini G; Regev E; Tessone A; Liran A; Haik J; Mendes D; Orenstein A; Winkler E
Dermatol Surg; 2007 Dec; 33 Suppl 2():S199-206; discussion S206. PubMed ID: 18086059
[No Abstract] [Full Text] [Related]
46. Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up.
Alijotas-Reig J; Garcia-Gimenez V; Miró-Mur F; Vilardell-Tarrés M
Dermatol Surg; 2009 Feb; 35 Suppl 1():360-6. PubMed ID: 19207326
[TBL] [Abstract][Full Text] [Related]
47. Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds.
Cohen SR; Berner CF; Busso M; Clopton P; Hamilton D; Romano JJ; Rullan PP; Thaler MP; Ubogy Z; Vecchione TR
Dermatol Surg; 2007 Dec; 33 Suppl 2():S222-30. PubMed ID: 18086062
[TBL] [Abstract][Full Text] [Related]
48. Late Onset Complications Secondary to Polyacrylamide Hydrogel-Based Filler for Rehabilitation of HIV-Related Facial Lipoatropy.
Rauso R; Califano L; Rugge L; Chirico F; Tartaro G
Aesthet Surg J; 2018 Oct; 38(11):NP170-NP174. PubMed ID: 30321286
[No Abstract] [Full Text] [Related]
49. Clinical and instrumental evaluation of a cross-linked hyaluronic acid filler dermal injection: effects on nasolabial folds skin biophysical parameters and augmentation from a single-dose, monocentric, open-label trial.
Cameli N; Mariano M; Serio M; Berardesca E
G Ital Dermatol Venereol; 2016 Oct; 151(5):507-14. PubMed ID: 27139014
[TBL] [Abstract][Full Text] [Related]
50. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.
Christensen LH
Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755
[TBL] [Abstract][Full Text] [Related]
51. Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study.
Mole B; Gillaizeau F; Carbonnel E; Pierre I; Brazille P; Grataloup C; Mercier S; Duracinsky M; Weiss L; Piketty C
AIDS Res Hum Retroviruses; 2012 Mar; 28(3):251-8. PubMed ID: 21801082
[TBL] [Abstract][Full Text] [Related]
52. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up.
Krhut J; Martan A; Jurakova M; Nemec D; Masata J; Zvara P
Int Urogynecol J; 2016 Feb; 27(2):301-5. PubMed ID: 26342812
[TBL] [Abstract][Full Text] [Related]
53. Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler.
Fernández-Cossío S; Castaño-Oreja MT
Plast Reconstr Surg; 2006 May; 117(6):1789-96. PubMed ID: 16651952
[TBL] [Abstract][Full Text] [Related]
54. Delayed inflammatory reaction to bio-alcamid polyacrylamide gel used for soft-tissue augmentation.
Chrastil-LaTowsky B; Wesley NO; MacGregor JL; Kaminer MS; Arndt KA
Arch Dermatol; 2009 Nov; 145(11):1309-12. PubMed ID: 19917963
[TBL] [Abstract][Full Text] [Related]
55. Aquamid: where is the reality?
Ankorina-Stark I
Plast Reconstr Surg; 2009 May; 123(5):1634. PubMed ID: 19407642
[No Abstract] [Full Text] [Related]
56. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds.
Lindqvist C; Tveten S; Bondevik BE; Fagrell D
Plast Reconstr Surg; 2005 Jan; 115(1):282-9. PubMed ID: 15622265
[TBL] [Abstract][Full Text] [Related]
57. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules.
Narins RS; Dayan SH; Brandt FS; Baldwin EK
Dermatol Surg; 2008 Jun; 34 Suppl 1():S2-8; discussion S8. PubMed ID: 18547177
[TBL] [Abstract][Full Text] [Related]
58. A Comparison of the Efficacy and Safety Between Hyaluronic Acid and Polylactic Acid Filler Injection in Penile Augmentation: A Multicenter, Patient/Evaluator-Blinded, Randomized Trial.
Yang DY; Ko K; Lee SH; Lee WK
J Sex Med; 2019 Apr; 16(4):577-585. PubMed ID: 30833149
[TBL] [Abstract][Full Text] [Related]
59. Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report.
DeLorenzi C; Weinberg M; Solish N; Swift A
Dermatol Surg; 2006 Feb; 32(2):205-11. PubMed ID: 16442040
[TBL] [Abstract][Full Text] [Related]
60. [Long-term complications after injection of permanent tissue-fillers to the lips].
Sneistrup C; Hölmich LR; Dahlstrøm K
Ugeskr Laeger; 2009 Apr; 171(17):1414. PubMed ID: 19413943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
